1. Home
  2. RUM vs PGEN Comparison

RUM vs PGEN Comparison

Compare RUM & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rumble Inc.

RUM

Rumble Inc.

HOLD

Current Price

$5.32

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.49

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RUM
PGEN
Founded
2013
1998
Country
United States
United States
Employees
135
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
RUM
PGEN
Price
$5.32
$3.49
Analyst Decision
Hold
Buy
Analyst Count
1
5
Target Price
$10.00
$7.67
AVG Volume (30 Days)
1.9M
4.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$230,981,000.00
Revenue This Year
$176.02
$342.78
Revenue Next Year
$135.29
$478.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.67
$1.11
52 Week High
$10.99
$5.47

Technical Indicators

Market Signals
Indicator
RUM
PGEN
Relative Strength Index (RSI) 43.65 40.67
Support Level $5.20 $3.43
Resistance Level $6.67 $5.10
Average True Range (ATR) 0.31 0.21
MACD 0.00 -0.03
Stochastic Oscillator 52.03 26.50

Price Performance

Historical Comparison
RUM
PGEN

About RUM Rumble Inc.

Rumble Inc is a free-to-use video-sharing platform where users can watch, share, like, comment, and upload their own videos. Users can subscribe to channels to stay in touch with recent creator content and access video-on-demand uploaded, and live content streamed, by creators. Geographically, it generates a majority of its revenue from the United States.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: